Activation of the PI3K/Akt/mTOR signalling pathway has been shown to be an important risk factor for early recurrence and poor prognosis in HCC patients [36], as this signalling pathway can regulate cell cycle, survival, metabolism, invasion and angiogenesis. The gene discussed is MTOR; the disease is hepatocellular carcinoma.